Cantel Medical (CMN) Misses Q2 EPS by 2c

Cantel Medical (NYSE: CMN) reported Q2 EPS of $0.26, $0.02 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $135.4 million versus the consensus estimate of $142.6 million.

For earnings history and earnings-related data on Cantel Medical (CMN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c